A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Recruiting

Phase 2

Phase 3

Glioblastoma RegimensA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Sponsor:

Global Coalition for Adaptive Research

Code:

NCT03970447

Conditions

Glioblastoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Temozolomide

Lomustine

Regorafenib

Radiation

Paxalisib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by Global Coalition for Adaptive Research on 2025-09-09.